Pericholangitis in Chronic Ulcerative Colitis: Primary Sclerosing Cholangitis of the Small Bile Ducts?
Overview
Affiliations
Review of liver biopsy specimens, autopsy specimens, and clinical records of 107 patients with chronic ulcerative colitis and hepatobiliary diseases showed "pericholangitis" (defined as small-duct primary sclerosing cholangitis) in 37 (35%), primary sclerosing cholangitis (defined as large-duct primary sclerosing cholangitis) in 18 (17%), chronic active hepatitis in 14 (13%), cryptogenic cirrhosis in 12 (11%), and miscellaneous lesions including malignancies in 26 (24%). Documented cirrhosis was present or developed in 37 patients (35%). The spectrum of histologic features of small-duct primary sclerosing cholangitis was indistinguishable from that of confirmed large-duct primary sclerosing cholangitis. In 6 of the 18 patients who eventually developed the large-duct disease, biopsy evidence 1 to 12 years earlier had shown small-duct primary sclerosing cholangitis. Thus, small-duct and large-duct primary sclerosing cholangitis seem to be components of a disease spectrum.
Primary Sclerosing Cholangitis Limited to Intrahepatic Bile Ducts Has Distinctly Better Prognosis.
Are V, Gromski M, Akisik F, Vilar-Gomez E, Lammert C, Ghabril M Dig Dis Sci. 2024; 69(4):1421-1429.
PMID: 38347369 DOI: 10.1007/s10620-023-08260-1.
Colitis ameliorates cholestatic liver disease via suppression of bile acid synthesis.
Gui W, Hole M, Molinaro A, Edlund K, Jorgensen K, Su H Nat Commun. 2023; 14(1):3304.
PMID: 37280200 PMC: 10244448. DOI: 10.1038/s41467-023-38840-8.
Liver-side of inflammatory bowel diseases: Hepatobiliary and drug-induced disorders.
Mazza S, Soro S, Verga M, Elvo B, Ferretti F, Cereatti F World J Hepatol. 2022; 13(12):1828-1849.
PMID: 35069993 PMC: 8727201. DOI: 10.4254/wjh.v13.i12.1828.
Vanishing Bile Duct Syndrome in a Patient with Uterine Cancer and Paraneoplastic Systemic Sclerosis.
Sedhom D, Herrmann A, DSouza M, Fyfe B, Zaldana F, Schlesinger N ACG Case Rep J. 2019; 5:e95.
PMID: 30643839 PMC: 6317838. DOI: 10.14309/crj.2018.95.
Clinical guidelines for primary sclerosing cholangitis 2017.
Isayama H, Tazuma S, Kokudo N, Tanaka A, Tsuyuguchi T, Nakazawa T J Gastroenterol. 2018; 53(9):1006-1034.
PMID: 29951926 PMC: 8930933. DOI: 10.1007/s00535-018-1484-9.